Loading chat...
FL H0293
Bill
Status
11/3/2025
Primary Sponsor
Gallop Franklin
Click for details
AI Summary
-
Agency for Health Care Administration must seek federal approval within 30 days of the act becoming law to cover continuous glucose monitors and related supplies as a durable medical equipment benefit under Medicaid
-
Licensed durable medical equipment providers must be reimbursed for continuous glucose monitors when claims are submitted through the Medicare Healthcare Common Procedure Coding System
-
Providers cannot be required to use a National Drug Code number when submitting claims for continuous glucose monitors
-
Agency may still provide additional coverage of continuous glucose monitors as a Medicaid pharmacy benefit
-
Implementation begins upon receiving necessary federal approval; act takes effect immediately upon becoming law
Legislative Description
Continuous Glucose Monitors
Last Action
1st Reading (Original Filed Version)
1/13/2026